AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

INDP · NASDAQ · Biotechnology

Indaptus Therapeutics (INDP)

Develops systemically administered bacterial immunotherapy for cancer and antiviral applications.

$1.16

Pre-market+0.01 (+1.08%)

At close$1.15(+1.33%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions6 holders · as of Mar 31, 2026	0.05%	70.6K shares
Insiders9 holders · as of Jun 26, 2026	48.75%	64.95M shares
Strategic holders1 holder · as of Apr 2, 2026	29.19%	38.90M shares
Otherremainder	22.01%	29.32M shares

133.24M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (133.24M in the company's Sep 3, 2026 report, 113.24M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Yun YaoInsider10 percent owner	31.51%	41.99M	13Dfiled Jun 26, 2026 ↗
SINO LION VENTURES LtdStrategic10 percent owner	29.19%	38.90M	Form 4filed Apr 2, 2026 ↗
Junyi DaiInsiderofficer: Chief Executive Officer	8.44%	11.25M	13Dfiled Jun 26, 2026 ↗
Yang TingInsider	8.44%	11.25M	13Dfiled Jun 26, 2026 ↗
Jeffrey A. MecklerInsiderdirector, 10 percent owner, officer: Co-Chief Executive Officer	0.17%	229,929	Form 4filed Dec 29, 2025 ↗
Michael James NewmanInsiderdirector, officer: CSO and Director	0.08%	101,074	Form 4filed Dec 29, 2025 ↗
Walt Addison LinscottInsiderofficer: Chief Operating Officer	0.04%	54,426	Form 4filed Dec 29, 2025 ↗
Citadel Advisors LLCInstitution	0.03%	39,018	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	0.02%	27,007	13Fas of Mar 31, 2026
Nir SassiInsiderofficer: Chief Financial Officer	0.02%	26,758	Form 4filed Dec 29, 2025 ↗
Avraham Ben-TzviInsiderdirector	0.02%	25,100	Form 4filed Jan 22, 2026 ↗
Matthew Charles McMurdoInsiderdirector	0.02%	25,000	Form 4filed Feb 26, 2026 ↗
Morgan StanleyInstitution	0.00%	2,697	13Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution	0.00%	1,890	13Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution	0.00%	17	13Fas of Mar 31, 2026
CWM, LLCInstitution	0.00%	2	13Fas of Mar 31, 2026
Bio Investments, Inc.Institution	—12.80% of class, as filed	—	13Dfiled Aug 13, 2021 ↗
David E. LazarInsiderofficer: Co-Chief Executive Officer	0.00%	0	Form 4filed Dec 23, 2025 ↗
Michael J. Newman, Ph.D.Insider	—25.70% of class, as filed	—	13Dfiled Aug 13, 2021 ↗
Glen R. Anderson¹Insider10 percent owner	0.03%	42,514	Form 4filed Aug 16, 2023 ↗
Hoonmo Lee²Insiderdirector, 10 percent owner	0.02%	24,804	Form 4filed Aug 6, 2021 ↗
Boyan Vesselinov Litchev³Insiderofficer: Chief Medical Officer	0.00%	41	Form 4filed Dec 19, 2022 ↗
Anthony J. Maddaluna⁴Insiderdirector	0.00%	24	Form 4filed Aug 2, 2021 ↗

Last filed Aug 16, 2023; leaving the company requires no filing. Not in the bar.
Last filed Aug 6, 2021; leaving the company requires no filing. Not in the bar.
Last filed Dec 19, 2022; leaving the company requires no filing. Not in the bar.
Last filed Aug 2, 2021; leaving the company requires no filing. Not in the bar.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

6 holders · 70.6K shares · 4 new positions · 4 increased · 1 reduced · 2 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Citadel Advisors LLC	39.0K	0.03%	+39.0Knew	May 15, 2026
Geode Capital Management, LLC	27.0K	0.02%	+27.0Knew	May 15, 2026
Morgan Stanley	2.7K	0.00%	+2.7Knew	May 15, 2026
Tower Research Capital LLC (TRC)	1.9K	0.00%	−1.3K	May 15, 2026
Sbi Securities Co., Ltd.	17	0.00%	0	Apr 28, 2026
CWM, LLC	2	0.00%	+2new	May 14, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Lazar David E.	47.93%		13D	Mar 24, 2026 ↗
Yao Yun	31.51%	41.99M	13D	Jun 26, 2026 ↗
Sino Lion Ventures Ltdincl. Chenhao Xu	29.19%	38.90M	13D	Jun 26, 2026 ↗
Jeffery A. Meckler	12.70%		13D	Dec 30, 2025 ↗
Dai Junyi	8.44%	11.25M	13D	Jun 26, 2026 ↗
Yang Ting	8.44%	11.25M	13D	Jun 26, 2026 ↗
A. Meckler	6.90%		13D/A	Nov 26, 2024 ↗
Newman Michael James	5.40%		13D	Dec 30, 2025 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Mar 23, 2026	David E. Lazardirector	Sale · 2 lots	896,800		103,200

CongressHouse and Senate disclosures

Not reported.